Treatments of nonalcoholic fatty liver disease in adults who have no other illness: A Review article

Sepideh Ahadi; Afshin Gharekhani; Afshin Shiva

doi:10.1016/j.ajg.2019.11.004

Treatments of nonalcoholic fatty liver disease in adults who have no other illness: A Review article

Arab J Gastroenterol. 2019 Dec;20(4):189-197. doi: 10.1016/j.ajg.2019.11.004. Epub 2019 Dec 2.

Authors

Sepideh Ahadi¹, Afshin Gharekhani², Afshin Shiva³

Affiliations

¹ Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.
² Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
³ Department of Clinical Pharmacy, Nephrology and Kidney Transplant Research Center, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: shiva@umsu.ac.ir.

PMID: 31806408
DOI: 10.1016/j.ajg.2019.11.004

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases. In the absence of treatment, NAFLD can damage the liver tissue and even have extra-hepatic complications. No therapeutic regimen has ever been approved for the treatment of this disease. A variety of clinical trials have been conducted in the field of NAFLD. Reviewing these trials is necessary to provide the most effective treatments. In this article, we aimed to review randomized controlled trials that evaluate the effects of pharmacological agents on NAFLD adults without other illness.

Keywords: Adults; Nonalcoholic fatty liver; Pharmacotherapy.

Publication types

Review

MeSH terms

Adult
Anti-Inflammatory Agents / therapeutic use*
Combined Modality Therapy
Humans
Lipid Regulating Agents / therapeutic use*
Non-alcoholic Fatty Liver Disease / drug therapy*
Non-alcoholic Fatty Liver Disease / therapy
Randomized Controlled Trials as Topic
Treatment Outcome
Weight Loss

Substances

Anti-Inflammatory Agents
Lipid Regulating Agents